Maravai LifeSciences
MRVI
MRVI
215 hedge funds and large institutions have $3.72B invested in Maravai LifeSciences in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 92 increasing their positions, 75 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
8% less funds holding
Funds holding: 234 → 215 (-19)
17% less capital invested
Capital invested by funds: $4.51B → $3.72B (-$789M)
41% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 39
Holders
215
Holding in Top 10
2
Calls
$6.21M
Puts
$2.65M
Top Buyers
| 1 | +$106M | |
| 2 | +$68.1M | |
| 3 | +$27.3M | |
| 4 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
+$26.2M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$20.9M |
Top Sellers
| 1 | -$154M | |
| 2 | -$35.3M | |
| 3 | -$33M | |
| 4 |
Millennium Management
New York
|
-$15.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$11.4M |